DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LIOTHYRONINE SODIUM

« Back to Dashboard

Clinical Trials for Liothyronine Sodium

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00004062	Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer	Completed	National Cancer Institute (NCI)	Phase 1	RATIONALE: Azacitidine may help thyroid cancer cells regain the ability to take up iodine. This would allow the cancer to be detected and treated by radioactive iodine. PURPOSE: Phase I trial to study the effectiveness of azacitidine to restore thyroid function in treating patients who have persistent or metastatic thyroid cancer.
NCT00004062	Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer	Completed	Lucille P. Markey Cancer Center at University of Kentucky	Phase 1	RATIONALE: Azacitidine may help thyroid cancer cells regain the ability to take up iodine. This would allow the cancer to be detected and treated by radioactive iodine. PURPOSE: Phase I trial to study the effectiveness of azacitidine to restore thyroid function in treating patients who have persistent or metastatic thyroid cancer.
NCT00027417	Study of Triostat in Infants During Heart Surgery	Completed	Michael Portman	Phase 3	This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery.
NCT00098852	Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer	Unknown status	National Cancer Institute (NCI)	Phase 2	RATIONALE: Drugs such as rosiglitazone may make tumor cells more sensitive to radioactive iodine. PURPOSE: This phase II trial is studying how well rosiglitazone works in treating patients with locoregionally extensive or metastatic thyroid cancer.

Clinical Trial Conditions for Liothyronine Sodium

Condition Name

Condition Name for Liothyronine Sodium
Intervention	Trials
Healthy	2
Head and Neck Cancer	2
Hypercholesterolemia	1
Heart Defects, Congenital	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Liothyronine Sodium
Intervention	Trials
Heart Defects, Congenital	2
Thyroid Neoplasms	2
Thyroid Diseases	2
Head and Neck Neoplasms	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Liothyronine Sodium

Trials by Country

Trials by Country for Liothyronine Sodium
Location	Trials
United States	10
Indonesia	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Liothyronine Sodium
Location	Trials
District of Columbia	2
California	2
Washington	2
North Dakota	1
Minnesota	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Liothyronine Sodium

Clinical Trial Phase

Clinical Trial Phase for Liothyronine Sodium
Clinical Trial Phase	Trials
Phase 3	3
Phase 2	2
Phase 1/Phase 2	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Liothyronine Sodium
Clinical Trial Phase	Trials
Completed	6
Recruiting	2
Terminated	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Liothyronine Sodium

Sponsor Name

Sponsor Name for Liothyronine Sodium
Sponsor	Trials
National Cancer Institute (NCI)	3
Ipe, LLC	2
Mylan Pharmaceuticals	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Liothyronine Sodium
Sponsor	Trials
Other	9
Industry	4
NIH	3

Export unavailable in trial.
Subscribe for complete access.